U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739342) titled 'Evaluating the Occurrence of DKA in People With Type I Diabetes' on July 28.
Brief Summary: This study will evaluate the occurrences of Diabetes-related Ketoacidosis (DKA) in adult and pediatric individuals living with Type I diabetes while managing diabetes with Abbott's Continuous Monitoring Systems.
Study Start Date: Sept., 2026
Study Type: OBSERVATIONAL
Condition:
Type 1 Diabetes
Intervention:
DEVICE: Abbott Continuous Dual Glucose Ketone Monitoring System
Participant will utilize the Abbott Continuous Dual Glucose Ketone Monitoring System in place of the Standard of Care
Recruitment Status: NOT_YET_RECRUITING
Sponsor: A...